Amv Pharmachem Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 31-12-2024
- Paid Up Capital ₹ 0.10 M
as on 31-12-2024
- Company Age 6 Year, 3 Months
- Last Filing with ROC 31 Mar 2022
- Revenue %
(FY 2020)
- Profit -158.21%
(FY 2020)
- Ebitda -422.28%
(FY 2020)
- Net Worth -47.05%
(FY 2020)
- Total Assets 713.14%
(FY 2020)
About Amv Pharmachem
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Mohit Kapoor, Vijay Rathod, and Manzoor Ali serve as directors at the Company.
- CIN/LLPIN
U24100DL2018PTC339183
- Company No.
339183
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Sep 2018
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Amv Pharmachem Private Limited offer?
Amv Pharmachem Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Whey Protein, Aeronautical Instrument & Components, Aerospace Equipment.
Who are the key members and board of directors at Amv Pharmachem?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohit Kapoor  | Director | 20-Sep-2018 | Current |
| Vijay Rathod | Director | 20-Sep-2018 | Current |
| Manzoor Ali | Director | 01-Mar-2021 | Current |
Financial Performance of Amv Pharmachem.
Amv Pharmachem Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 158.21% decrease in profit. The company's net worth observed a substantial decline by a decrease of 47.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Amv Pharmachem?
Unlock access to Amv Pharmachem's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
_295147.webp)
Landmark Homebuild (India) Private LimitedActive 12 years 14 daysMohit Kapoor and Vijay Rathod are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Amv Pharmachem?
Unlock and access historical data on people associated with Amv Pharmachem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Amv Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amv Pharmachem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
